9Glomus Tumour (Paraganglioma) Management

FThe vascular tumour you can sometimes see

A paraganglioma — historically called a glomus tumour — is a slow-growing, highly vascular tumour arising from paraganglion cells. In the temporal bone it takes two main forms: glomus tympanicum, confined to the middle-ear promontory, and glomus jugulare, arising at the jugular bulb and often extending more widely. Its rich blood supply is exactly why it presents the way it does [2025].

The classic story is pulsatile tinnitus with a hearing change, and on otoscopy a reddish-blue mass behind the lower part of the eardrum that may blanch with pneumatic pressure (Brown sign). For the learner, the take-home is that pulsatile tinnitus plus a retrotympanic mass is a paraganglioma until proven otherwise — and it should never be biopsied in clinic because of the risk of brisk bleeding [2025].

TImaging to stage, not to biopsy

Diagnosis is made by imaging. High-resolution temporal bone CT shows the soft-tissue mass and, with jugulare tumours, the characteristic ’moth-eaten’ erosion of the jugular foramen. MRI with contrast demonstrates the lesion and its intracranial extent, often with a ’salt-and-pepper’ flow-void appearance, and angiography defines the feeding vessels [2013].

Staging classifications (Fisch and Glasscock-Jackson) group tumours by whether they are confined to the middle ear, involve the mastoid, erode the jugular bulb, or extend intracranially. Because some paragangliomas are catecholamine-secreting and a minority are part of a hereditary syndrome, evaluation also includes biochemical screening and consideration of genetic referral — the tumour staging then guides which treatment is realistic [2025].

CFour roads: surgery, embolisation, radiosurgery, observation

Management is individualised across four options. Microsurgical resection offers the only true cure and is favoured for small, accessible tumours — a glomus tympanicum can often be removed transcanal with excellent hearing outcomes, sometimes with laser assistance [2025]. For larger jugulare tumours with a vigorous arterial supply, preoperative embolisation (one to a few days before surgery) devascularises the lesion and substantially reduces intraoperative blood loss [2025].

Stereotactic radiosurgery has become a mainstay for jugular paragangliomas, particularly larger lesions or older patients in whom the morbidity of surgery near the lower cranial nerves is unacceptable; it does not excise the tumour but achieves durable growth control in the great majority [2025]. Conventional fractionated radiotherapy is an established alternative with high local control across head-and-neck paragangliomas [2026]. Finally, because many of these tumours grow very slowly, watchful waiting with serial imaging is entirely appropriate for small, asymptomatic lesions or frail elderly patients.

CLetting size and age choose

The decision framework is best understood as a trade-off between the cure that surgery offers and the morbidity it risks. A small glomus tympanicum in a fit patient is ideal for curative resection; a large glomus jugulare wrapped around the lower cranial nerves in an older patient is better served by radiosurgery, which trades cure for excellent growth control while sparing swallowing and voice [2025].

Preoperative embolisation should be reserved for hypervascular tumours headed for surgery, and observation for the smallest and the frailest. The unifying principle — shared with every vascular pulsatile tinnitus intervention — is matching the aggressiveness of the treatment to the threat of the lesion and the resilience of the patient [2026].